Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Neoplasms
×
durvalumab
×
90 days
×
Clear all
Filters
3
NCT06606847
2026-03-18
LADOGA
AstraZeneca
Phase 2
Active not recruiting
30 enrolled
NCT01042379
2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT05941897
2026-03-05
LOTOS
AstraZeneca
Phase 2
Active not recruiting
39 enrolled
NCT05063565
2026-03-02
ROWAN
Boston Scientific Corporation
Phase 2
Active not recruiting
100 enrolled
NCT05303532
2026-02-23
ROSY-D
AstraZeneca
Phase 3
Enrolling by invitation
214 enrolled